Engineering Life ■ 61
Life, Rewritten
The JCVI is just one institution among a large
group of universities and companies pursuing
synthetic biology, a field that aims to design
and construct new biological entities with novel
and useful functions. Scientists are working
to create algae that digest trash and produce
energy, microbes that use light and water to
create hydrogen gas, and bacteria that produce
new kinds of antibiotics to treat infections. With
synthetic biology “we can harness what nature
has made, but repurpose it,” says James Collins,
a synthetic biologist at Boston University. “We
can reprogram organisms and endow them with
novel functions.” In addition to useful tools, the
pursuit of artificial life sheds light on the very
origins of life. “It’s going to be a big challenge to
create a totally synthetic cell,” says Collins, “but
it’s fundamentally intriguing to explore how life
may have arisen on the planet.”
To make their own cell, scientists are pushing
the boundaries of cell theory, one of the unify-
ing principles of biology. Cell theory has two
main parts: every living organism is composed
of one or more cells, and all cells living today
came from a preexisting cell. By trying to engi-
neer a cell in the laboratory, Venter, Gibson, and
others are challenging the second part of the
definition.
Starting Small
The JCVI’s first step toward a synthetic cell was
a small one. In 2003, Venter’s team flexed its
scientific muscles by synthesizing the 11-gene,
5,386-base-pair genome of phiX174, a virus that
infects bacteria. A virus is a small, infectious
agent that can replicate only inside a living cell.
Most viruses are little more than stripped-down
genetic material wrapped in proteins, yet these
pathogens attack and devastate organisms in
every kingdom of life, from bacteria to plants
and animals. Though the JCVI team success-
fully created a virus with a synthetic genome,
it was not considered the first synthetic life,
because scientists debate whether viruses are
alive. (For more on this debate, see “Viruses—
Living or Not?,” page 66.)
Next, Venter and his colleagues moved up to
a bacterium, a living organism that consists of
a single cell. In 2010, they sequenced and built
the genome of a bacterium called Mycoplasma
mycoides (M. mycoides), an organism that can
cause the mammary glands of goats to swell.
They constructed the genome—a 1.1-million-
base-pair DNA sequence—using four neces-
sary ingredients: the nucleotides adenine (A),
thymine (T), guanine (G), and cytosine (C),
the building blocks of DNA. A, T, G, and C, orga-
nized in different combinations, carry all the
instructions for everything a cell does.
The team used a machine to read the nucle-
otide sequence of the M. mycoides genome and
then “print out” little bits of that code, creating
strands of DNA about 50–80 bases long. They
then strung these pieces together using living
cells as factories, inserting the short segments
into yeasts and Escherichia coli—small, single-
celled organisms. These organisms interpreted
the strands as broken pieces of DNA and
stitched them together, creating longer and
longer sequences. It was like building the Eiffel
Tower from a massive box of Legos, construct-
ing a single support beam at a time. The effort—
with many mistakes along the way—took years.
“It was very complex,” said Venter. “It was a long,
involved process.”
Congratulations, It’s a Cell
Once the DNA sequence of Mycoplasma mycoides
was complete and intact, it was up to the JCVI
team to transfer it into another species and make
it work. This was the experiment that almost
drove Gibson crazy. The researchers removed all
the DNA from a cell of a closely related bacte-
rium, Mycoplasma capricolum, and replaced it
with the M. mycoides synthetic DNA.
After months of trying, on that Monday morn-
ing at 5:00 a.m., Gibson cautiously scanned the
J. Craig Venter is an American biologist and founder
and CEO of the J. Craig Venter Institute. He led a team
to fully sequence and publish the human genome in
2001, and initiated the effort to create the first cell
constructed with synthetic DNA.
J. CRAIG VENTER